Search | Page 8 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results

    ... engraftment was 12 days (range 8-21 days) and for platelet engraftment was 19 days (range 8-154 days). The incidence was ...

    Research Article last updated 02/01/2017 - 12:30pm.

  2. Transplant saves student who thought she had mono

    ... to get home for the holidays. I chalked the mono and low platelet count up to being super-stressed, and made an appointment to see ...

    Article last updated 03/06/2017 - 2:37pm.

  3. Efficacy, safety, and pharmacokinetics of subcutaneous azacitidine in Taiwanese patients with higher-risk myelodysplastic syndromes

    ... transfusion independence and 7 of 18 attained platelet transfusion independence. Most common grade 3-4 treatment-emergent ...

    Research Article last updated 02/03/2017 - 10:05am.

  4. Clinical applications of haploidentical hematopoietic stem cell transplantation in severe aplastic anemia

    ... (ANC) > 0.5×109/L, and the average time of 15.0d for platelet count was more than 20×109/L. Follow-up for 1 month later ...

    Research Article last updated 02/03/2017 - 9:36am.

  5. Battling Aplastic Anemia, Seeking Information

    ... with a rare blood disorder. I was bruising easily, and my  platelet  count was dangerously low. I was diagnosed to have ITP, had my ...

    Patient Chronicle last updated 04/26/2018 - 10:30am.

  6. Design and rationale of the QUAZAR Lower-Risk MDS (AZA-MDS-003) trial: a randomized phase 3 study of CC-486 (oral azacitidine) plus best supportive care vs placebo plus best supportive care in patients with IPSS lower-risk myelodysplastic syndromes and po

    ... who may have required red blood cell or platelet transfusions. The overall response rate was 40 %, including ... include overall survival, hematologic response including platelet response and erythroid response, RBC transfusion independence ...

    Research Article last updated 06/23/2016 - 10:17am.

  7. Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan

    ... were observed, especially in patients with platelet count ≥150 × 109/L. Approximately 97 % of patients showed ...

    Research Article last updated 11/02/2016 - 10:39am.

  8. Alternative Donor Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Refractory Severe Aplastic Anemia

    ... was 25 (range, 2 to 58) days, and to last platelet transfusion to keep platelets counts over 50 × 103/mm3 was ...

    Research Article last updated 01/24/2017 - 10:04am.

  9. Patient Inspires Workplace Giving

    ... over my body caused by bleeding into the skin due to low platelet counts. After I got to know what the symptoms of aplastic ...

    Patient Chronicle last updated 06/28/2016 - 8:12am.

  10. Builds supportive community to help him with MDS and bone marrow transplant

    ... severely bleeding gums, for which he required his first platelet transfusion . Continuing drops in hemoglobin levels ...

    Patient Chronicle last updated 04/26/2018 - 10:50am.